Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma

NCT01257230

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.444.01004 Boehringer Ingelheim Investigational Site Plymouth, Minnesota, United States

205.444.01005 Boehringer Ingelheim Investigational Site Columbia, Missouri, United States

205.444.01001 Boehringer Ingelheim Investigational Site Cincinnati, Ohio, United States

205.444.01014 Boehringer Ingelheim Investigational Site Oklahoma City, Oklahoma, United States

View all 66 locations

View Trial Details

Completed

Single Dose Bronchodilatory Study in Asthma

NCT01805687

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Northeast Medical Research Associates North Dartmouth, Massachusetts, United States

View Trial Details

Completed

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

NCT00523952

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Brno, Czechia

Hradec Králové, Czechia

Ostrava, Czechia

Pilsen, Czechia

View all 25 locations

View Trial Details

Completed

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

NCT00535691

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Halifax, Canada

Vancouver, Canada

Waterloo, Canada

Helsinki, Finland

View Trial Details

Completed

Protopic Ointment in Adult Atopic Eczema of the Face

NCT00690105

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +12 more
Locations: Nice, France

View Trial Details

Completed

Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

NCT00567762

Conditions: Conjunctival Diseases, Conjunctivitis, Conjunctivitis, Allergic, +7 more
Locations: Ehime, Japan

Hokkaido, Japan

Kagoshima, Japan

Kochi, Japan

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

NCT00691145

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: S. Giovanni Rotondo, Foggia, Italy

Battipaglia, Salerno, Italy

Ancona, Italy

Bari, Italy

View all 26 locations

View Trial Details

Completed

Protopic Ointment in Children Atopic Eczema

NCT00689832

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Paris, France

View Trial Details

Completed

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

NCT00691262

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Bologna, Italy

Catania, Italy

Genova, Italy

Lecco, Italy

View Trial Details

Completed

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

NCT00560326

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Halifax, Canada

Vancouver, Canada

Waterloo, Canada

Helsinki, Finland

View Trial Details

Hypersensitivity, Immediate

Hypersensitivity, Immediate trial results

Related conditions